Answers are grounded in this paper and cite their sources.
Solution 1H and 13C, and solid-state 13C CPMAS NMR data are reported for the rubazoic acid derivatives 4-(5-hydroxy-1,3-dimethylpyrazol-4-ylmethylidene)-1,3-dimethyl-2-pyrazolin-5-one 1, 4-(5-hydroxy-1,3-dimethylpyrazol-4-ylimino)-1,3-dimethyl-2-pyrazolin-5-one 2, 4-(5-hydroxy-1-phenyl-3-aminopyrazol-4-ylmethylidene)-1-phenyl-3-amino-2-pyrazolin-5-one 3, and 4-(5-hydroxy-1-p-sulfophenylene-3-methylpyrazol-4-ylmethylidene)-1-p-sulfophenylene-3-methyl-pyrazolin-5-one 4. Solution 15N NMR chemical shifts have also been measured, lsotopic 2H shifts for the OH signal in CDCI3 for the first two compounds were found to be +0.28 ± 0.03 and +0.40 ± 0.03 ppm respectively. AM1-calculated molecular geometries are also reported. The overall results support the idea of a fast proton transfer equilibrium between two enolic tautomers both in solution and in the solid state. The degeneracy of the tautomers is removed in crystals.
No takes yet. Share an insight, caveat, or question.
Olivieri et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: